ACAD

EPS: 0.02 Rev: 268M Net Inc: 4M

Income Statement

Expenses

Assets

Assets (Current)

Assets (Non-Current)

Liabilities

Liabilities (Current)

Liabilities (Non-Current)

Cash Flow

Cash Flow Investing

Dimension Breakdowns

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax

srt:MajorCustomersAxis

Leaf Members

srt:ProductOrServiceAxis, us-gaap:StatementBusinessSegmentsAxis

Leaf Members

ACAD vs Biotechnology (37 peers) - Healthcare

Gross Margin

94.3%

+15.6pp vs peers

Operating Margin

9.8%

-26.8pp vs peers

Net Margin

36.5%

+6.6pp vs peers

Related: REGN INCY VRTX CPRX UTHR ALKS JAZZ MRNA PTCT APLS